This is a public webinar. You can register here.

Long Covid affects as many as 150,000 people in New Zealand. Shockingly, they report a quality of life similar to that of patients with severe cancer or severe MS.

As the public focus on Covid-19 has waned and the public has largely returned to ‘normal’, many patients and health experts worry that the debilitating burden of long Covid is going unacknowledged. Public efforts to reduce transmission have largely stalled, yet each new case of long Covid has a profound and potentially life-long impact on patients and their whānau, as well as on our wider health and economic system.

In this webinar our expert panel will help us explore several important questions:

  • More than four years since Covid-19 made itself known, what do we know about long Covid and how to treat it?
  • How does the condition impact New Zealanders and their quality of life? Do we know the size of the problem, and who is most affected?
  • Are patients getting the support they need?
  • What policy and public health interventions are needed to reduce the risks of more people developing long Covid, and to help support those who have it already?
  • Where do we go from here? Is the government taking this seriously?

 

Our panel of experts includes:

Michael Baker – Professor of Public Health, University of Otago. Michael was a leading architect and advocate for the Covid-19 elimination strategy, and a member of the Ministry of Health’s Covid-19 Technical Advisory Group. He established a programme of research on the epidemiology, prevention and control of Covid-19 (Co-Search), which has generated a large amount of published research and commentary on the illness, and he continues to be a vocal advocate for public health policy approaches to reduce transmission.

Paula Lorgelly – Professor of Health Economics and Population Health at Auckland University. Paula is lead investigator in the establishment of a registry of long Covid patients that aims to paint an accurate picture of the burden of the condition.

Jenene Crossan – Patient advocate with Long Covid Support Aotearoa. As one of the first people to contract Covid-19 in New Zealand, Jenene has been a vocal advocate for long Covid patients. She has been working with Paula to help establish the Long Covid registry.

Warren Tate – Emeritus Professor of Biochemistry, Otago University. Warren has been researching the pathophysiology and treatment of ME/CFS for decades. Since 2021 his research has focused on both conditions – particularly the similarities between them. Warren trains clinicians on treating ME/CFS and long Covid, and has been a strong advocate for patient needs and policy changes.

Read more